Best Life Sciences Tech Companies in Tel Aviv, Israel
The 34 best Life Sciences Tech companies in Tel Aviv, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Quris Ai.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Tel Aviv
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Quris Ai AI-based drug candidate predicting tool for healthcare professionals | $37M | 46 mo ago | Seed | Isaac Bentwich Co-Founder & CEO | 2020 | Wix eCommerceWixSentry+15 | — | — |
| 2 | BeaconCure Developer of an AI-enabled statistical analysis platform for biometrics teams 16Moat top 41%Funding top 46%Talent bottom 49%Market bottom 43% All 9 signals ▾Moattop 41% Fundingtop 46% Talentbottom 49% Marketbottom 43% Techbottom 38% Patentsbottom 35% Globalbottom 29% Newsbottom 22% Innovationbottom 21% Moat: Editorial + unicorn rating 7/10 · IP moat: 2 patents Funding: Raised $25.9M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 16/100 | $26M | 21 mo ago | Series C | Ilan Carmeli COO & Co-Founder | 2016 | — | 2 patents Automated validation and quality assurance for tabular summary reports | — |
| 3 | QuantHealth Provider of AI-based clinical trail management tool for researchers 55AI top 30%Funding top 34%Growth top 35%Moat top 39% All 9 signals ▾AItop 30% Fundingtop 34% Growthtop 35% Moattop 39% Techtop 42% Talentbottom 49% Newsbottom 42% Globalbottom 38% Marketbottom 32% AI: Classified as an AI company · Product described with: ai-based Funding: Raised $22.0M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) rank vs industry peers · Fliar Intelligence Index 55/100 | $22M | 12 mo ago | Series A | Orr Inbar Co-Founder & CEO | 2020 | DatoCMSApple iCloud MailGoogle Workspace+20 | — | — |
| 4 | Protai Provider of AI-enabled platform for proteomics based drug discovery and development | $20M | 43 mo ago | Seed | — | 2021 | WebflowReactcore-js+13 | — | — |
| 5 | Mana.bio AI-based drug delivery technology for research and development | $20M | 36 mo ago | Seed | Yogev Debbi Co-Founder & CEO | 2021 | WixSentryBootstrap+11 | — | — |
| 6 | Geneyx Provider of a clinical genetics data management platform for hospitals and genetic labs | $10M | 59 mo ago | Seed | — | 2018 | WordPressBetterDocsMySQL+37 | — | — |
| 7 | Promise Provider of AI-based platform for personalised treatment plans 62Talent top 28%AI top 45%Global top 45%Funding top 47% All 6 signals ▾Talenttop 28% AItop 45% Globaltop 45% Fundingtop 47% Moattop 48% Marketbottom 49% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 62/100 | $8M | 22 mo ago | Seed | Ronel Veksler Co-Founder & CEO | 2020 | — | — | — |
| 8 | Genome Compiler Corporation Provider of DNA design & visualization, data management and collaboration | $5M | 156 mo ago | Acqui-Hired | Omri Amirav-Drory Founder & CEO | 2011 | — | 2 patents Synthetic DNA design and manufacturing workflow software (bioinformatics CAD for polynucleotides). | — |
| 9 | STARLIMS Technologies Digital LIMS for reserach labaratory | — | 9 mo ago | Acquired | Trey Cook President and Chief Executive Officer | 1987 | — | 2 patents Graphical tools for designing software connectivity drivers (data integration interfaces) | — |
Top 9 Life Sciences Tech companies in Tel Aviv
#1
Series A · Tel Aviv, Tel Aviv · founded 2020 · 21 employees$22Mraised▾
Provider of AI-based clinical trail management tool for researchers. It allow users to evaluate each parameter independently, or discover the optimal protocol that maximizes efficacy and safety.
- Oct 2025Series A—
- Jan 2024Series A$2M
- Aug 2023Series A$15M
- Oct 2022Seed$2.6M
#2
Series C · Tel Aviv, Tel Aviv · founded 2016 · 27 employees$25.9Mraised▾
Developer of an AI-enabled statistical analysis platform for biometrics teams. The platform unifies review roles within a fit-for-purpose environment. It enhances visible collaboration, accountability, and efficiency. The AI algorithms are refined through metadata extraction and expert feedback. The platform delivers validation, data transformation, and metadata reuse. An automated activity log maintains a real-time audit trail.
- Jan 2025Series C$15M
- Jun 2023Series B$14M
- Mar 2023Series A$9.9M
- Nov 2021Seed$2M
#3
Seed · Tel Aviv, Tel Aviv · founded 2020$8.3Mraised▾
Provider of AI-based platform for personalised treatment plans. It utilizes a cloud-based AI platform to perform unbiased epiproteomic analyses on standard mass-spectrometry data, optimizing personalized treatment plans and facilitating disease diagnosis.
- Dec 2024Grant (prize money)—
- Dec 2024Seed$8.3M
#4
Seed · Tel Aviv, Tel Aviv · founded 2021 · 17 employees$19.5Mraised▾
AI-based drug delivery technology for research and development. It offers machine learning and nanotechnology platformr to identify formulations of lipid nanoparticles drug delivery systems, gene therapy including DNA and RNA-based therapeutics, and vaccines.
- Oct 2023Seed$19.5M
#5
Seed · Tel Aviv-Yafo, Tel Aviv · founded 2020 · 45 employees$37Mraised▾
AI-based drug candidate predicting tool for healthcare professionals. The company has developed software that assists with the drug development process. It has features for clinical predictive tools, clinical trial management, drug development process management, and more.
- Dec 2022Seed$9M
- Jan 2022Seed$19M
- Oct 2021Seed$9M
#6
Seed · Tel Aviv, Tel Aviv · founded 2021 · 11 employees$20Mraised▾
Provider of AI-enabled platform for proteomics based drug discovery and development
- Mar 2023Seed$12M
- Jan 2022Seed$8M
#7
Seed · Herzliya, Tel Aviv · founded 2018 · 31 employees$10Mraised▾
Provider of a clinical genetics data management platform for hospitals and genetic labs. The company offers an AI-based solution for next-generation sequencing (NGS) data, customizable workflows, rapid phenotype-driven interpretation, and Integrations that can scale the process of FASTQ to clinical reports for hospital and commercial labs.
- Nov 2021Seed$10M
#8
Acqui-Hired · Tel Aviv, Tel Aviv · founded 2011 · 22 employees$5Mraised▾
Genome Compiler Corporation provides a software platform that enables genetic engineers, and molecular and synthetic biologists for DNA design and visualization, data management, and collaboration. It offers Genome Compiler, a platform that provides design tools, plasmids and parts repositories, connections to DNA synthesis providers, and lab automation services that help to generate combinatorial design for projects. Genome Compiler Corporation was incorporated in 2011 and is based in Los Altos, California.
- Oct 2013Series A—
- 2013Series A$2M
- 2011Conventional Debt$1M
- 2011Series A$3M
#9
Acquired · Tel Aviv, Tel Aviv · founded 1987—raised▾
Digital LIMS for reserach labaratory
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Israel
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 267 Israel-affiliated papers.
- Ministry of Agriculture118
- Hebrew University of Jerusalem29
- Agricultural Research Organization25
- Tel Aviv University21
- Ben-Gurion University of the Negev19
- Mitochondrion1→5
- Gene1→18
- Plant disease resistance1→7
- Resistance (ecology)2→6
- Agriculture3→6
Where biotechnology is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.